Full-Time

Director – Transformation Analytics

Posted on 4/27/2025

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
Data Analysis
Excel/Numbers/Sheets
Financial Modeling
Requirements
  • Doctorate degree and 4 years of Data Analytics / Finance experience OR
  • Master’s degree and 14 to 16 years of Data Analytics / Finance experience OR
  • Bachelor’s degree and 16 to 18 years of Data Analytics / Finance experience
  • 6+ years of managerial experience directly managing people and/or leadership experience leading teams, projects, programs or directing the allocation of resources
  • Proficiency in Microsoft Excel
  • Proficiency in financial modeling, data analytics and business intelligence tools
  • Understanding of financial data and systems
Responsibilities
  • Oversee multiple small teams focused on the development of comprehensive resource and financial analyses for Tech and workforce strategy program
  • Direct the reporting of insights on Tech & Workforce Strategy program
  • Provide leadership in building and maintaining functional ambitions for teams
  • Oversee the creation of complex cases, incorporating multiple data sources
  • Oversee data validation of the Value Confirmation analysis, review executive summary outputs
  • Guide teams in identifying and reconciling deviations from the approved case
  • Oversee analysis efforts to optimize workforce and resource allocation, driving efficiency across the business
  • Oversee the development of models for long-term planning and decision-making, ensuring strategic alignment
  • Oversee data integration across multiple teams to ensure insights are aligned with business priorities and performance objectives
  • Oversee design and implement automated data workflows for complex datasets, collaborating with business and IT teams to expand automation and integrate it with existing systems
  • Collaborate with cross-functional global teams to ensure accurate insights' delivery, operating in the 'following-the-sun' model
  • Interact with various finance and resource planning groups across Amgen to understand impact to budget/long range plans
  • Influence cross-functional key collaborators to leverage single source of truth of transformation data being built in OPI&A (Organization planning, insights & analytics)
Desired Qualifications
  • 5+ years of managerial experience directly managing people and/or leadership experience leading teams, projects, programs or directing the allocation of resources
  • Mastery of complex financial modeling (Excel)
  • Understanding of global Finance, HR & Procurement systems and data
  • Understanding of HR/Procurement/Global Sourcing operations
  • Experience in budgeting, forecasting, and strategic planning
  • Understanding of impacts of business decisions to financial statements (P&L, B/S, Cash Flow)
  • Understanding of / experience in the Bio-Pharmaceutical industry
  • Business transformation experience involving recent technology advancements
  • Prior multinational corporate experience (capability center or other)
  • Experience with Oracles Hyperion/EPM, SAP, Anaplan, PowerBI / Tableau
  • Experience with data analysis, data modeling, and data visualization solutions such as Tableau, Alteryx, Databricks, PowerBI
  • Experience working with business partners to identify complex functionality and translate it into requirements
  • Experience in preparing executive communication to include written and oral presentations.
  • Experience in financial planning, analysis, and reporting, ERP systems and financial software

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.